Figure 5
(A, B) Representative immunohistochemical CD31 staining of skin wounds samples from from diabetic (db+/db+) mice treated with vehicle (6 μl of 0.9% NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C) Comparison of semi-quantitative assessment of microvascular density (MVD) between each group. Each bar represents the mean±S.D. of six animals. *P<0.05 compared with db+/+m+vehicle; §P<0.01 compared with db+/+m+vehicle; #P<0.01 compared with db+/db++vehicle.
CD31 staining and MVD score

(A, B) Representative immunohistochemical CD31 staining of skin wounds samples from from diabetic (db+/db+) mice treated with vehicle (6 μl of 0.9% NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C) Comparison of semi-quantitative assessment of microvascular density (MVD) between each group. Each bar represents the mean±S.D. of six animals. *P<0.05 compared with db+/+m+vehicle; §P<0.01 compared with db+/+m+vehicle; #P<0.01 compared with db+/db++vehicle.

Close Modal

or Create an Account

Close Modal
Close Modal